IE users: please get the latest browser version at Microsoft Internet Explorer Home Page
if yot already have the latest browser version please verify that your browser settings is not in compatibility mode
Mesenchymal precursor cells (MPCs) are isolated from human bone marrow aspirates by density gradient separation, over Ficoll, followed by STRO-3-based immunoselective magnetic activated cell sorting (MACS); cultures are then expanded. STRO-3 is a monoclonal antibody, which reacts with an epitope of non-specific, human tissue alkaline phosphatase. Stro3 binds to the immunizing stromal cells, but lacks reactivity with peripheral blood-derived mononuclear cells.
Culture-expanded MPCs demonstrate increased gene expression of a range of stem cell markers, when compared to mesenchymal stem cells (MSCs), and exhibit a greater capacity to undergo osteogenic, adipogenic and chondrogenic differentiation.
STRO-3-selected MPCs were plated as single-cell suspensions at a density of 8x10^3 cells per cm^2, in αMEM supplemented with FCS (10%), L-ascorbate-2-phosphate (100 µM), β-mercaptoethanol (50 µM) and Primocin (100 µg/ml).